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Abstract: To elucidate the mechanisms by which type 2 Diabetes Mellitus (DM2) constitutes a risk
factor for the development and progression of osteoarthritis (OA), this work determined whether
high glucose and/or high insulin, the hallmarks of DM2, are capable of activating the transcription
factor, Nuclear Factor-κB (NF-κB), which plays a critical role in OA by inducing the expression of
pro-inflammatory and catabolic genes. For this, we analyzed NF-κB activation by measuring the
nuclear levels of p65 by western blot. As readouts of NF-κB activity, Interleukin-1β, Tumor Necrosis
Factor-α, and inducible nitric oxide synthase (iNOS) expression were analyzed by real time RT-PCR
and western blot. Culture of the human chondrocytic cell line, C28-I2, in high glucose (30 mM)
increased nuclear NF-κB p65 levels in a time-dependent manner, relative to cells cultured in medium
containing 10 mM glucose (regular culture medium). High glucose-induced NF-κB activation was
inhibited by co-treatment with its specific inhibitor, Bay 11-7082, 5 µM. Culture of primary human
chondrocytes under high glucose for 24 h increased IL-1β and TNF-α mRNA levels by 97% (p = 0.0066)
and 85% (p = 0.0045), respectively, while iNOS mRNA and protein levels and NO production increased
by 61% (p = 0.0017), 148% (p = 0.0089), and 70% (p = 0.049), respectively, relative to chondrocytes
maintained in 10 mM glucose. Treatment of chondrocytic cells with 100 nM insulin was also sufficient
to increase nuclear NF-κB p65 levels, independently of the glucose concentration in the culture
medium. This study shows that hyperglycemia and hyperinsulinemia are independently sufficient to
induce inflammatory responses in human chondrocytes, namely by activating NF-κB. This can be a
relevant mechanism by which DM type 2 and other conditions associated with impaired glucose and
insulin homeostasis, like obesity and the metabolic syndrome, contribute to the development and
progression of OA.
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1. Introduction
Aging is the major risk factor for osteoarthritis (OA), but other factors have been recognized [1,2],
including diabetes mellitus (DM), especially type 2 (DM2), and impaired glucose homeostasis. Recent
epidemiologic studies demonstrated that DM is an independent risk factor for OA development and
progression [3,4], supporting the notion of a specific diabetes-induced OA phenotype [1,2]. How DM
and impaired glucose homeostasis contribute to cartilage and joint destruction is largely unknown.
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Chronic low grade inflammation is a major OA driver, being associated with other mechanisms
involved in OA pathogenesis, including cell senescence, oxidative stress, mitochondrial dysfunction,
and impaired autophagy [5,6], which together contribute to cell depletion and imbalanced anabolic
and catabolic responses, especially in chondrocytes [7].
All the above mechanisms have been associated with the effects of hyperglycemia and have been
implicated in the pathogenesis of DM and its complications. Moreover, all these mechanisms have
also been related to inflammation, which is currently accepted as an important effector mechanism by
which DM2 causes cell and tissue damage [8].
Only a few studies have been conducted so far to identify direct effects of high glucose in articular
chondrocytes, collectively indicating that hyperglycemia-like glucose concentrations favor catabolic
processes and impair anabolic responses [9–13], especially in chondrocytes from OA/aged articular
cartilage [11,12]. Moreover, high glucose has also been shown to directly induce the expression of
interleukin (IL)-6 and cyclooxygenase 2 [13], two important inflammatory mediators, as well as to
potentiate the same inflammatory responses induced by interleukin-1β (IL-1β) [14].
Given the central role of the transcription factor, Nuclear factor-κB (NF-κB), in inflammation and
in OA [15], this study aimed at determining whether high, hyperglycemia-like, glucose concentrations
are sufficient to activate this transcription factor and the expression of its pro-inflammatory target
genes. Among these, IL-1β, Tumor Necrosis Factor (TNF)-α, and the inducible isoform of the Nitric
Oxide Synthase (iNOS), the enzyme responsible for the production of large amounts of NO [16], play
critical roles in OA pathophysiology [17]. For that purpose, we compared NF-κB activation in human
chondrocytes cultured in regular (10 mM glucose) or high glucose media (30 mM) by measuring its
nuclear accumulation. Since NF-κB activation is required for the expression of pro-inflammatory
and catabolic genes in human chondrocytes, we also evaluated the expression of IL-1β, TNF-α, and
iNOS in chondrocytes cultured in regular (10 mM) and high (30 mM) glucose containing media as
readouts of NF-κB activity. As hyperinsulinemia often accompanies DM2 and it has been reported
to have both protective and pathological roles in different cells, including inhibition of autophagy in
OA models [5,6], we also evaluated its ability to modulate inflammatory responses in chondrocytes
cultured in regular or in high glucose media.
2. Materials and Methods
2.1. Chondrocyte Isolation and Treatments
Human articular cartilage samples were collected and processed for cell isolation and culture
within 24 h post-mortem from the distal femoral condyles of multi-organ donors (44–73 years old,
mean = 59.4, n = 11) at the Orthopedic Department and Bone Bank of the Hospital and University
Centre of Coimbra (CHUC). The cartilage samples were variably degraded, ranging from mild to
severely damaged. Therefore, each sample was graded 0–4 according to the degree of macroscopic
damage using the Outerbridge classification in which 0 corresponds to normal undamaged cartilage
and 4 to severely damaged cartilage with full depth erosion. In this study, cartilage samples of grades 2
to 4 were used. All procedures were approved by the Health Ethics Committee of CHUC (authorization
number: 0204/8654/DC, date: 12/16/2013).
Upon enzymatic isolation and to avoid chondrocyte dedifferentiation, confluent non-proliferating
monolayer cultures were setup by plating 1 × 106 chondrocytes/mL in the appropriate conditions
as previously described [11]. The human chondrocytic cell line, C28/I2, was kindly provided by
Prof. Mary Goldring (currently at the Hospital for Special Surgery, New York, NY, USA) and Harvard
University. For each experiment, 0.5 × 106 chondrocytes/mL were plated and allowed to recover
for 24 h. Prior to any treatment, the cells were serum-starved for at least 8 h and then, cultured in
serum-free conditions in regular Ham F-12 (Sigma-Aldrich, St. Louis, MO, USA), which contains
10 mM glucose, or in the same medium supplemented with glucose to a final concentration of 30 mM
(high glucose) for the periods indicated in figure legends. Osmotic effects of high glucose were ruled
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out by adding 20 mM mannitol, a non-absorbable polysaccharide, to the regular culture medium.
To confirm the mechanism involved in NF-κB activation, chondrocyte cultures in high glucose were
simultaneously treated with 5 µM of the specific inhibitor, Bay-11-7082 (Sigma-Aldrich, St. Louis, MO,
USA) [18]. To evaluate the effects of insulin, serum-deprived chondrocyte cultures in regular or high
glucose medium were supplemented with insulin to achieve physiologic (10 nM) or supraphysiologic
(100 nM) concentrations.
2.2. Nitric Oxide Production
NO production was evaluated as the concentration of nitrite accumulated in the supernatants of
primary chondrocyte cultures maintained in 10 or 30 mM glucose for 72 h. Nitrite concentration was
measured using the spectrophotometric method based on the Griess reaction [19].
2.3. Western Blot Analysis
Nuclear and total cell extracts were prepared and subjected to western blot as described
previously [11]. The membranes were probed with monoclonal antibodies against human iNOS (R&D
systems, Minneapolis, MN, USA) and NF-κB p65 (Cell Signalling, Boston, MA, USA) O/N at 4 ◦C and
after extensive washings, with alkaline phosphatase-conjugated secondary antibodies (GE Healthcare,
Buckinghamshire, UK) for 1 h at room temperature. Anti-human β-tubulin (Sigma-Aldrich) and
anti-human Lamin B1 (Abcam, Cambridge, UK) were used to detect loading controls for total cell and
nuclear extracts, respectively. Immune complexes were detected with the Enhanced ChemiFluorescence
reagent (GE Healthcare) and the bands were analyzed using ImageQuant™ TL (version 7.0, GE
Healthcare). The results were normalized by calculating the ratio between the intensities of the bands
corresponding to the protein of interest and to the loading control.
2.4. Total RNA Extraction and Quantitative Real-Time RT-PCR (qRT-PCR)
Total RNA extraction, reverse transcription, and quantitative real-time PCR were performed as
described previously [11]. Specific sets of primers for iNOS, IL-1β, TNF-α, and HPRT-1 (Gen Accession
Numbers NM_000625.4, NM_000576.2, NM_000594.3, and NM_000194.2, respectively) were designed
using Beacon Designer software (PREMIER Biosoft International, Palo Alto, CA, USA).
Gene expression changes were analyzed using the built-in iQ5 Optical system software v2 by the
Pfaffl method, a variation of the ∆∆CT method corrected for gene-specific efficiencies [20].
The results for each gene of interest were normalized against HPRT-1, the housekeeping gene
found to be the most stable under the experimental conditions used (data not shown).
2.5. Statistical Analysis
Results are presented as mean ± SEM representing the results of, at least, three independent
experiments in which chondrocytes were isolated from, at least, three distinct donors. Cartilage from
distinct donors was not pooled and each donor contributed only once for each experiment. Statistical
analysis was performed using GraphPad Prism (version 5.00). The Kolmogorov-Smirnov test was
used to assess the normality and homogeneity of variances to determine whether parametric tests
could be used. As this test showed that the results were normally distributed in all experiments, the
statistical analysis was performed using the two-tailed paired Student t-test between control and high
glucose or high insulin conditions. Results were considered significant at p < 0.05.
3. Results
3.1. High-Glucose Induces NF-κB p65 Translocation to the Nucleus
As human cartilage samples are limited and a large number of cells was required, the human
chondrocytic cell line, C-28/I2, was used to evaluate the ability of high glucose to activate the
transcription factor, NF-κB. Activation of this transcription factor can occur through two distinct
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pathways of which the canonical pathway occurs in most cell types and requires the phosphorylation
and subsequent ubiquitination and proteasomal degradation of inhibitory proteins, termed Inhibitor
of NF-κB (IκB), which, in basal conditions, retain NF-κB dimers in the cytoplasm [18,21]. Once IκBs, in
particular IκB-α, are degraded, NF-κB translocates to the nucleus promoting the transcription of its
target genes. Therefore, activation of this transcription factor leads to its nuclear translocation that can
be detected as the nuclear accumulation of p65 (Rel A), a major component of NF-κB dimers found in
chondrocytes [22].
The results obtained show that nuclear p65 levels gradually increased during culture in high
glucose, peaking at 1 h (Figure 1). After 2 h, nuclear levels of p65 were identical to those found in
control conditions (10 mM glucose), and remained as such until up to, at least, 24 h, the longest period
tested. No changes in nuclear p65 levels were observed in cells maintained in control conditions
(10 mM glucose) for up to 1440 min (data not shown). The control in Figure 1 corresponds to cells
maintained in these conditions for 120 min.
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To further confirm the mechanism involved in high glucose-induced NF-κB activation, the cells 
were co-treated with the specific NF-κB inhibitor, Bay-11-7082. The results in Figure 1 show that, at 
the concentration of 5 µM which was shown to be sufficient to inhibit NF-κB activation in 
chondrocytes and other joint tissue cells [23,24], Bay 11-7082 completely reversed the effect induced 
by high glucose. This indicates that high glucose induces NF-κB activation through the canonic 
pathway, that is, phosphorylation, ubiquitination, and degradation of IκBs and consequent release 
and nuclear translocation of NF-κB dimers. 
To rule out osmotic effects, the culture medium containing 10 mM glucose was supplemented 
with 20 mM mannitol, a non-absorbable polysaccharide, thus corresponding in terms of osmolarity, 
to the medium containing 30 mM glucose. No significant changes in the nuclear levels of p65 were 
observed in cells cultured in this medium for 1 h (mean =91.4 ± 11.9, p = 0.2574) relative to the control 
(Ctrl, 10 mM glucose), indicating that the effects detected with high glucose (HGM, 30 mM glucose) 
are not due to osmotic stimulation (Figure 2). 
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To further confirm the mechanism involved in high glucose-induced NF-κB activation, the
cells were co-treated with the specific NF-κB inhibitor, Bay-11-7082. The results in Figure 1 show
that, at the concentration of 5 µM which was shown to be sufficient to inhibit NF-κB activation in
chondrocytes and other joint tissue cells [23,24], Bay 11-7082 completely reversed the effect induced by
high glucose. This indicates that high glucose induces NF-κB activation through the canonic pathway,
that is, phosphorylation, ubiquitination, and degradation of IκBs and consequent release and nuclear
translocation of NF-κB dimers.
To rule out osmotic effects, the culture medium containing 10 mM glucose was supplemented
with 20 mM mannitol, a non-absorbable polysaccharide, thus corresponding in terms of osmolarity,
to the medium containing 30 mM glucose. No significant changes in the nuclear levels of p65 were
observed in cells cultured in this medium for 1 h (mean =91.4 ± 11.9, p = 0.2574) relative to the control
(Ctrl, 10 mM glucose), indicating that the effects detected with high glucose (HGM, 30 mM glucose)
are not due to osmotic stimulation (Figure 2).
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Figure 3. Role of high glucose in modulating pro-inflammatory cytokines and inducible nitric oxide
synthase (iNOS) expression. mRNA levels of iNOS, interleukin (IL)-1β, and Tumor Necrosis Factor
(TNF)-α were measured in primary human chondrocytes cultured for 24 h in control (Ctrl, 10 mM) or in
high glucose (30 mM) medium. Each column represents the mean ± SEM of, at least, four independent
experiments. ** p < 0.01 relative to Ctrl.
Moreover, the increase in iNOS mRNA induced by 30 mM glucose was accompanied by a si ilar
increase of th protein l vel (Figure 4A) and enzy e activity, as shown by the aug e t product on
of NO (Figure 4B).
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3.3. High Insulin Induced NF-κB p65 Translocation to the Nucleus
To determine whether insulin alone modulates the inflammatory state of human chondrocytes,
we evaluated the effect of physiologic (10 nM) and supraphysiologic (100 nM) insulin concentrations
on nuclear p65 levels in C28-I2 cells cultured in regular (Ctrl, 10 mM) glucose medium. Figure 5 shows
that treatment of cells under regular glucose with 100 nM insulin is sufficient to increase nuclear p65
levels, and this increase is identical to that observed in cells cultured in high glucose (30 mM) alone.
No changes in nuclear p65 levels were observed upon treatment with 10 nM insulin alone relative to
control conditions (10 mM glucose).
To determine whether physiologic or supraphysiologic insulin concentrations modulate high
glucose-induced NF-κB activation, chondrocyte cultures were treated simultaneously with 30 mM
glucose and 10 or 100 nM insulin for 1 h. The results in Figure 5 show that although the mean value
obtained in cells treated with 10 nM insulin in the presence of high glucose is higher than that obtained
with high glucose alone, the difference did not reach statistical significance. Moreover, treatment of cells
under high glucose with 100 nM insulin also did not change nuclear p65 levels relative to high glucose
(30 mM) alone, thus indicating that insulin, either at physiologic or supraphysiologic concentrations,
and high glucose neither synergize nor antagonize each other in inducing NF-κB activation.
4. Discussion
The results presented show that culture of human chondrocytes under high glucose is sufficient
to induce NF-κB activation. The rapid nuclear translocation of p65 induced by high glucose suggests
a direct ffect on the NF-κB sign ling pathway i chondrocytes. I a previous study, we reported
that cultur of human aged/OA chondrocytes u der high glucose elicits the prolonged production of
reactiv xygen species (ROS) [11], which were shown to mediate IL-1β-induced NF-κB activation and
the expression of iNOS in chondrocytes [25]. Taking these stu ies together, it se ms likely that high
glucos -induced NF-κB activation can result, at least in part, from th incr as d production of ROS
elicited by the intracellular glucose ccumulation observed in aged/OA chondrocytes ex osed to high
glucose [11]. The observation that the le tive inhibitor of the canonical NF-κB activation pathway,
Bay 11-7082, completely abrogated high glucose-induced NF-κB activation sh ws that the response to
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high glucose occurs through this pathway and further supports a possible role for ROS, since these
have been shown to be required for IL-1β-induced IκB-α degradation in chondrocytes [18,25]. Further
studies will be directed at confirming this association and evaluating the efficacy of antioxidants in
preventing high glucose-induced NF-κB activation and the expression of its dependent genes.
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added to C28-I2 cultures in regular (10 mM) or high glucose (30 mM) conditions for 1 h. Each column
represents the mean ± SEM of, at least, four independent experiments. * p < 0.05 and *** p < 0.001
relative to the control (10 mM glucose).
Moreover, the results presented also show that the expression of inflammatory mediators relevant
in OA pathogenesis, namely IL-1β, TNF-α, and iNOS, was also upregulated by high glucose. Since
the role of NF-κB in inducing the expression of these pro-inflammatory genes in chondrocytes is
well established, these results indicate that NF-κB activation by high glucose is likely the underlying
mechanism, although other processes may also be involved. Nonetheless, upregulated iNOS mRNA
levels were detected upon culture in high glucose for 24 h, whereas measurable amounts of the protein
and NO were detected after 72 h and required culture periods longer than, at least, 48 h. Moreover,
NF-κB activation was maximal after exposure to high glucose for 1 h, while by 2 h the effect had
returned to levels found in control cells cultured in regular medium (10 mM glucose) for the same
period and remained as such for, at least, 24 h (1440 min). This kinetics of NF-κB activation is similar to
that observed with other stimuli, like IL-1β, which allows iNOS protein to be detected much earlier [22]
than observed here with high glucose. This suggests that other mechanisms required to induce iNOS
expression and protein synthesis are delayed in response to high glucose when compared to IL-1β. One
possibility is that high glucose-induced iNOS expression is preceded and mediated by the expression
of IL-1β and TNF-α, which are potent inducers of iNOS expression in chondrocytes [16]. Other
possibilities may be related to the modulation of other signaling pathways that contribute to increase
NF-κB transcriptional activity after its release from IκB proteins. In this context, p65 phosphorylation
and acetylation are known to increase its transcriptional activity [21], but how such modifications
affect the expression of each NF-κB-dependent gene is largely unknown. Thus, it is possible that
high glucose is not as efficient as IL-1β and TNF-α in inducing those modifications, thus requiring
a longer period or even being unable to induce full NF-κB activity. Although out of the scope of
this study, elucidating the molecular mechanisms involved in high glucose-induced NF-κB activation
and how such mechanisms affect individual gene expression will be important to understand the
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mechanisms by which DM2 contributes to OA development and progression and eventually to design
new preventive or therapeutic strategies.
Insulin is essential for maintenance of glucose homeostasis and for proper maintenance of the
energetic balance, but also contributes to maintain anabolic processes in several tissues, including
cartilage, as it was shown to induce anabolic and inhibit catabolic responses in adult chondrocytes
and cartilage explant cultures from various species [12,26]. In DM2 and the metabolic syndrome,
hyperinsulinemia occurs as an attempt at maintaining glucose homeostasis, at least while pancreatic β
cells remain functional. Accumulating evidence, however, is unraveling a role for hyperinsulinemia
in driving or, at least, contributing to the low-grade inflammation and tissue damage characteristic
of those metabolic disorders and their complications [27]. For instance, supraphysiologic insulin
concentrations, similar to or higher than those we used, were shown to induce NF-κB activation and
synergize with TNF-α in cardiac myoblasts [28], while in chondrocytes they decreased autophagy
and increased IL-1β and MMP-13 expression, contributing to cartilage degradation [5]. Thus, we
hypothesized that physiologic and supraphysiologic insulin concentrations may have distinct effects
in chondrocytes, either alone or in combination with high glucose. The results obtained confirmed
this hypothesis, showing that supraphysiologic insulin concentrations are sufficient to activate NF-κB
in chondrocytes while physiologic concentrations have no effect, either alone or in combination with
high glucose. Nonetheless, we observed no additive or synergistic effects of the association of high
insulin and high glucose in terms of NF-κB activation, while autophagy was found to be further
impaired by high insulin in the presence of high glucose [5]. Taken together, the results presented
here also suggest that by activating NF-κB, hyperinsulinemia can induce inflammatory responses in
chondrocytes. Nonetheless, more studies are required to further elucidate the direct pro-inflammatory
effects of hyperinsulinemia in primary human chondrocytes.
5. Conclusions
In summary, the results presented here, along with the pro-catabolic and anti-anabolic effects
that we and others reported previously [11,12], further support the hypothesis that hyperglycemia
per se can drive cartilage damage and OA, in agreement with in vivo studies that showed increased
joint damage associated with a more intense inflammatory response in animal models of DM2 [13,14].
Moreover, the results obtained also indicate that hyperinsulinemia, which is characteristic of DM2
and metabolic syndrome, can also by itself contribute to activate an inflammatory state in human
chondrocytes that can accelerate OA development and progression. Thus, these findings corroborate
the hypothesis that hyperglycemia and hyperinsulinemia are relevant pro-inflammatory mediators
in human chondrocytes, hence giving support to further studies both in vitro and in animal models
of impaired glucose and insulin homeostasis in order to assess their relevance in OA development
and progression. Such studies, although out of the scope of the current study, will elucidate the
consequences to joint tissues homeostasis of the complex dynamic interactions between hyperglycemia
and hyperinsulinemia. This knowledge will be essential for the development of new preventive and
therapeutic strategies for DM-associated OA.
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